Study identifies NLS region as key regulator of TDP-43 protein self-assembly in neurodegeneration
Researchers found that the disordered nuclear localization signal (NLS) region of TDP-43, particularly its basic amino acids, controls how the protein assembles into clusters and aggregates linked to neurodegenerative diseases. TDP-43 cytosolic inclusions are hallmarks of amyotrophic lateral sclerosis and frontotemporal dementia, making understanding its aggregation mechanisms important for disease research. The findings suggest a specific mutation (K82A) may be a better model for studying TDP-43 mislocalization than commonly used alternatives.
A bioRxiv preprint reports that the disordered NLS-region of TDP-43 plays a crucial regulatory role in the protein's self-assembly across multiple size scales, from small clusters to visible condensates and aggregates. Using molecular dynamics simulations and NMR spectroscopy, researchers demonstrated that the NLS-region engages in inter-chain interactions with C-terminal aromatic residues and other protein domains. The study compared various NLS mutations and found that while commonly used mutations significantly reduce or eliminate TDP-43 self-assembly, a minimal K82A mutation preserves condensation both in vitro and in living cells. This distinction is important because accurate cellular models of TDP-43 aggregation are essential for understanding the pathological mechanisms underlying amyotrophic lateral sclerosis and frontotemporal dementia. The authors propose K82A as a superior model system for future cell and animal studies of cytosolic TDP-43 aggregation.
Limitations & open questions
The study's own limitations are not detailed in the provided abstract. Additionally, the timeline for when these findings might translate to therapeutic applications, and whether the K82A model recapitulates all aspects of disease-relevant TDP-43 pathology, remain open questions not addressed in the excerpt.
What different sources said
- bioRxivCenter
TDP-43 self-assembly is regulated by its disordered NLS-region
Related
Researchers Identify D-Retro-Inverso Peptide Candidates for Treating Cardiac Amyloidosis
Researchers have designed and computationally evaluated four peptide candidates made from D-amino acids that may inhibit the formation of Serum Amyloid A (SAA) fibrils associated with cardiac complications following heart attacks. The study builds on mouse model evidence suggesting SAA aggregates contribute to long-term myocardial infarction complications and may operate similarly in humans. Two candidates, DRI-R5S and DRI-H6A, were identified as particularly promising for potential drug development.
Study Identifies D-Retro-Inverso Peptides as Potential Treatments for Cardiac Amyloidosis
Researchers designed four peptide candidates using D-amino acids to inhibit Serum Amyloid A (SAA) fibril formation, which may contribute to complications following heart attacks. The study, conducted using molecular dynamics simulations in a mouse model, identified two peptides—DRI-R5S and DRI-H6A—as promising drug candidates. This work could lead to new therapeutic approaches for cardiac amyloidosis, a serious post-infarction complication.
Scientists Discover Previously Unknown Branch of Tryptophan Metabolism in Humans
Researchers identified a new enzymatic step in human tryptophan catabolism, showing that the protein ASPDH acts as a 2-aminomuconate reductase to produce a previously unknown amino acid. This discovery fills a gap in the kynurenine pathway, one of the body's major metabolic routes for processing the amino acid tryptophan. The finding expands understanding of human metabolism and may have implications for understanding NAD cofactor production and related metabolic diseases.